174 related articles for article (PubMed ID: 29695933)
1. Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population.
He J; Zhuo ZJ; Zhang A; Zhu J; Hua RX; Xue WQ; Zhang SD; Zhang JB; Li XZ; Jia WH
Cancer Manag Res; 2018; 10():765-774. PubMed ID: 29695933
[TBL] [Abstract][Full Text] [Related]
2. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
Sun Y; Wu Y; Li W; Kong Z; Zou X
Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Mo J; Luo M; Cui J; Zhou S
Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
[TBL] [Abstract][Full Text] [Related]
5. Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility.
Yang F; Mu X; Bian C; Zhang H; Yi T; Zhao X; Lin X
J Cell Biochem; 2019 Sep; 120(9):15635-15647. PubMed ID: 31081240
[TBL] [Abstract][Full Text] [Related]
6. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy.
Lu ZM; Luo TH; Nie MM; Fang GE; Ma LY; Xue XC; Wei G; Ke CW; Bi JW
Tumour Biol; 2014 Apr; 35(4):2941-8. PubMed ID: 24318989
[TBL] [Abstract][Full Text] [Related]
7. Association of ERCC1 Polymorphisms with the Risk of Colorectal Cancer: A Meta-Analysis.
Chen J; Sun N; Hu G; Chen X; Jiang J; Wu H; Luo G
Crit Rev Eukaryot Gene Expr; 2017; 27(3):267-275. PubMed ID: 29199611
[TBL] [Abstract][Full Text] [Related]
8. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variations in Nucleotide Excision Repair Pathway Genes and Risk of Allergic Rhinitis.
Liu W; Zeng Q; Zeng Y; Tang Y; Luo R
Mediators Inflamm; 2022; 2022():7815283. PubMed ID: 35693108
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of nucleotide excision repair genes associated with colorectal cancer risk: Meta-analysis and trial sequential analysis.
Yi C; Li T; Shen Y; Wang P; Dai L; Shi J; Wang K; Sun C; Ye H
Front Genet; 2022; 13():1009938. PubMed ID: 36386844
[No Abstract] [Full Text] [Related]
11. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis.
Zhu J; Hua RX; Jiang J; Zhao LQ; Sun X; Luan J; Lang Y; Sun Y; Shang K; Peng S; Ma J
PLoS One; 2014; 9(5):e97616. PubMed ID: 24841208
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis.
Lv Y; Xu M; Sun Y; Liu Y; Zhao L; Liu X; Li Z; Shi G; Jia J; Bi L; Ma N; Zhang X; Qi C
Medicine (Baltimore); 2021 Aug; 100(33):e26850. PubMed ID: 34414935
[TBL] [Abstract][Full Text] [Related]
13. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
Zhao F; Shang Y; Zeng C; Gao D; Li K
Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis.
Zhang L; Wang J; Xu L; Zhou J; Guan X; Jiang F; Wu Y; Fan W
Mutagenesis; 2012 Jan; 27(1):67-76. PubMed ID: 22002622
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population.
He J; Xu Y; Qiu LX; Li J; Zhou XY; Sun MH; Wang JC; Yang YJ; Jin L; Wei QY; Wang Y
PLoS One; 2012; 7(11):e49308. PubMed ID: 23166636
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer.
Liu J; Deng N; Xu Q; Sun L; Tu H; Wang Z; Xing C; Yuan Y
Oncotarget; 2016 Jul; 7(30):48130-48142. PubMed ID: 27340861
[TBL] [Abstract][Full Text] [Related]
17. ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY
PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723
[TBL] [Abstract][Full Text] [Related]
18. Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children.
Zhuo ZJ; Liu W; Zhang J; Zhu J; Zhang R; Tang J; Yang T; Zou Y; He J; Xia H
EBioMedicine; 2018 Apr; 30():113-119. PubMed ID: 29544698
[TBL] [Abstract][Full Text] [Related]
19. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
Zhou CX; Zhao JH
Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
[TBL] [Abstract][Full Text] [Related]
20. Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk.
Hui L; Yue S; Gao G; Chang H; Li X
Tumour Biol; 2014 Aug; 35(8):7451-7. PubMed ID: 24782032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
